O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.5%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.33B
AUM Growth
+$8.33B
(+4%)
Cap. Flow
-$6.28M
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
34.18%
Holding
150
New
16
Increased
26
Reduced
35
Closed
6
Top Buys
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$326M |
| 2 |
Elevance Health
ELV
|
$127M |
| 3 |
AGN
Allergan plc
AGN
|
$98.8M |
| 4 |
Dentsply Sirona
XRAY
|
$94.9M |
| 5 |
Inspire Medical Systems
INSP
|
$87.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$204M |
| 2 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$154M |
| 3 |
AbbVie
ABBV
|
$145M |
| 4 |
Tenet Healthcare
THC
|
$128M |
| 5 |
Bristol-Myers Squibb
BMY
|
$71.7M |
Sector Composition
| 1 | Healthcare | 94.35% |
| 2 | Financials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Teleflex
TFX
$5.59B
| $51.1M | 0.61% | 190,400 +73,400 | +63% | +$19.7M |
|
52
argenx
ARGX
$43.6B
| $49.7M | 0.59% | 599,300 +99,300 | +20% | +$8.23M |
|
53
KALA BIO
KALA
$78.8M
| $47.3M | 0.56% | 3,447,840 | – | – |
|
54
Galapagos
GLPG
$2.07B
| $44.9M | 0.54% | 486,990 | – | – |
|
55
Adicet Bio
ACET
$59.9M
| $44.2M | 0.53% | 4,830,387 | – | – |
|
56
eHealth
EHTH
$118M
| $40.5M | 0.48% | 1,834,700 | – | – |
|
|
ONC
57
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $40.2M | 0.48% | 261,400 -93,500 | -26% | -$14.4M |
|
|
OBSV
58
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $39.4M | 0.47% | 2,605,531 | – | – |
|
59
Zai Lab
ZLAB
$3.68B
| $37.5M | 0.45% | 1,611,000 +952,840 | +145% | +$22.2M |
|
60
Pediatrix Medical
MD
$1.5B
| $37.3M | 0.45% | 862,600 +492,600 | +133% | +$21.3M |
|
61
Tandem Diabetes Care
TNDM
$845M
| $37.2M | 0.44% | +1,689,000 | New | +$37.2M |
|
62
Cigna
CI
$80.3B
| $36.5M | 0.44% | 214,800 +22,500 | +12% | +$3.82M |
|
63
Exelixis
EXEL
$10.1B
| $36.2M | 0.43% | +1,681,200 | New | +$36.2M |
|
64
Pfizer
PFE
$141B
| $35.6M | 0.42% | 982,000 | – | – |
|
65
UnitedHealth
UNH
$281B
| $30.3M | 0.36% | +123,300 | New | +$30.3M |
|
66
Incyte
INCY
$16.5B
| $29.3M | 0.35% | +438,000 | New | +$29.3M |
|
67
Verrica Pharmaceuticals
VRCA
$52.8M
| $29.2M | 0.35% | +1,479,733 | New | +$29.2M |
|
68
CRISPR Therapeutics
CRSP
$4.71B
| $29.2M | 0.35% | 496,200 +391,799 | +375% | +$23M |
|
69
Assembly Biosciences
ASMB
$190M
| $28.3M | 0.34% | 721,166 | – | – |
|
|
IMGN
70
DELISTED
Immunogen Inc
IMGN
| $28.3M | 0.34% | 2,904,270 +1,400,000 | +93% | +$13.6M |
|
71
Gilead Sciences
GILD
$140B
| $25.8M | 0.31% | 364,600 | – | – |
|
|
INSY
72
DELISTED
Insys Therapeutics, Inc.
INSY
| $25.4M | 0.3% | 3,511,544 | – | – |
|
|
LPNT
73
DELISTED
LifePoint Health, Inc.
LPNT
| $25M | 0.3% | 513,200 -389,625 | -43% | -$19M |
|
|
ALPN
74
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $25M | 0.3% | 3,298,516 | – | – |
|
|
CTIC
75
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $24.9M | 0.3% | 5,000,000 | – | – |
|